Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
Beyond gastrointestinal effects, clinicians should monitor for several less common but clinically significant adverse events
Product Specifications Synonyms: LY3298176, P1206, tirzepatida, tirzepatidum CAS Number: 2023788-19-2 Molecular Formula: CHNO Molecular Weight: 4813.48 g/mol Peptide Sequence: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(C20)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH Purity: 95% (verified by HPLC and mass spectrometry) Packaging Format: 20 mg lyophilized powder in a sealed research-grade vial Storage Conditions: Store 28 C (20 C long term)
Low blood glucose (hypoglycemia)
This improved glucose control has several benefits, including reducing the risk of developing type 2 diabetes and reducing the risk of complications associated with diabetes
With respect to glycemic control, GLP-1 RAs activate GLP-1 receptors in the pancreas, leading to glucose-mediated enhancement of insulin release and reduction of glucagon release [7]
US$ 26.88
US$ 24.16
US$ 22.28
US$ 25.59
US$ 26.81
